VMP 36630511000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices
BNF code 0601012ABAAAAAA
Virtual Therapeutic Moiety Insulin glargine + Lixisenatide
Basis of preferred name Other
Prescribing status Caution - AMP level prescribing advised
Sugar free
Gluten free
Preservative free
CFC free
Non-availability Actual Products Available
Non-availability status date 11 Sep 2024
Dose form Discrete
Unit dose form size 3.000
Unit dose form units ml
Unit dose unit of measure pre-filled disposable injection
Virtual Product Ingredient
Ingredient Insulin glargine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 100.000
Strength value numerator unit unit
Strength value denominator 1.000
Strength value denominator unit ml
Virtual Product Ingredient
Ingredient Lixisenatide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 33.000
Strength value numerator unit microgram
Strength value denominator 1.000
Strength value denominator unit ml
Ontology Drug Form & Route
Form & Route solutioninjection.subcutaneous
Dose Form
Formulation Solution for injection
Drug Route
Route Subcutaneous
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Suliqua 100units/ml / 33micrograms/ml solution for injection 3ml pre-filled SoloStar pens (Sanofi)
Virtual Medicinal Product Packs
Insulin glargine 100units/ml / Lixisenatide 33micrograms/ml solution for injection 3ml pre-filled disposable devices 3 pre-filled disposable injection

dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.

Feedback